View Financial HealthLucy Scientific Discovery 배당 및 자사주 매입배당 기준 점검 0/6Lucy Scientific Discovery 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Sep 06The Nasdaq Stock Market to Delist Common Stock of Lucy Scientific DiscoveryThe Nasdaq Stock Market announced that it will delist the common stock of Lucy Scientific Discovery Inc. The company’s Securities were suspended on July 1, 2024, and have not traded on Nasdaq since that time.공시 • Jul 02Nasdaq Determines to Delist the Lucy Scientific Discovery's Common SharesAs previously disclosed, on May 7, 2024, Lucy Scientific Discovery Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating that based on the review of the Nasdaq staff, the Company’s lack of compliance with the requirement that a listed company’s stockholders’ equity be at least $2.5 million pursuant to Nasdaq Listing Rule 5550(b), would have lead to the suspension of the trading of the Company’s common shares at the opening of business on May 16, 2024. The Company needed to appeal the delisting determination by May 14th and request a hearing before an independent Nasdaq Hearings Panel to avoid this trading suspension. The Company timely submitted its appeal, which stayed the delisting of the Company’s securities on Nasdaq until the hearing was held on June 25, 2024. Furthermore, as previously disclosed, on May 21, 2024, the Company received a letter from the Staff stating that, per Nasdaq Listing Rule 5250(c)(1), the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024, which served as an additional basis for delisting the Company’s securities from Nasdaq. On June 25, 2024, the Company participated in a hearing before the Panel regarding its plan to regain compliance with the Minimum Stockholders’ Equity Requirement and the Filings Rule. On June 27, 2024, the Company received notice from Nasdaq that the Panel has determined to delist the Company’s common shares. Suspension of trading in the Company’s common shares will be effective at the open of trading on July 1, 2024. Following the delisting of its common shares from the Nasdaq Capital Market, the Company will continue to be a reporting company under the Securities Exchange Act of 1934. The Company expects its common shares will commence trading on the OTC Markets Group platform at the open of trading on July 1, 2024 under the symbol “LSDI.” The Company has a period of 15 days from the date of the notice letter to submit a written request for a review of the Panel’s delisting determination by the Nasdaq Listing and Hearing Review Council.공시 • May 29Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)Lucy Scientific Discovery Inc. announced that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule"). On May 21, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") that, per Nasdaq Listing Rule 5250(c)(1) (the "Filings Rule"), the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024, which serves as an additional basis for delisting the Company's securities from Nasdaq. The Company intends to request the continued listing of its common shares on Nasdaq pending its compliance with the Stockholders' Equity Rule and the Filings Rule. However, there can be no assurance that the Panel will grant the Company's request or that the Company will ultimately regain compliance with all applicable requirements for continued listing on Nasdaq.공시 • May 17Lucy Scientific Discovery Inc. announced delayed 10-Q filingOn 05/15/2024, Lucy Scientific Discovery Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 12Brian Zasitko, Chief Financial Officer of Lucy Scientific Discovery Inc., Resigns, Effective May 17, 2024On May 3, 2024, Brian Zasitko, Chief Financial Officer of Lucy Scientific Discovery Inc., resigned, effective May 17, 2024.공시 • May 11+ 1 more updateLucy Scientific Discovery Inc. Announces Resignation of Livio Susin, Member of the Board of DirectorsOn April 25, 2024, Livio Susin, a member of the Board of Directors of Lucy Scientific Discovery Inc., resigned, effective immediately. Mr. Susin did not resign as a result of any disagreement with the Company, known to an executive officer of the Company, on any matter relating to the Company's operations, policies or practices.공시 • Feb 17Lucy Scientific Discovery Inc. Announces 1-For-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementLucy Scientific Discovery Inc. announced that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The reverse share split will become effective on February 26, 2024 (the “Effective Date”), and the shares are expected to begin trading on the split-adjusted basis on the Nasdaq Stock Exchange (“Nasdaq”) under the Company's existing trading symbol “LSDI” at the market open on February 26, 2024. In conjunction with the reverse split, the new CUSIP number will be 54960E203. On the Effective Date, every 10 issued and outstanding shares of the Company’s Common Stock will be converted automatically into one share of the Company’s Common Stock without any change in the par value per share.New Risk • Feb 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$6.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$6.3m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 27% per year over the past 5 years. Revenue is less than US$1m (US$17k revenue). Market cap is less than US$10m (US$4.33m market cap). Minor Risk Shareholders have been diluted in the past year (8.4% increase in shares outstanding).Board Change • Dec 28High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Livio Susin is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Sep 28Lucy Scientific Discovery Receives Non-Compliance Notice From NasdaqOn September 21, 2023, Lucy Scientific Discovery Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, no par value per share (the “Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no immediate effect on the continued listing status of the Common Stock on The Nasdaq Capital Market, and, therefore, the Company's listing remains fully effective. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company is provided a compliance period of 180 calendar days from the date of the Notice, or until March 19, 2024, to regain compliance with the Minimum Bid Requirement. To regain compliance, the closing bid price of the Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to March 19, 2024. If the Company is not in compliance with the Minimum Bid Requirement by March 19, 2024, the Company may be afforded a second 180 calendar day compliance period. To qualify for this additional compliance period, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price requirement. The Company will continue to monitor the closing bid price of its Common Stock and seek to regain compliance with all applicable Nasdaq requirements within the allotted compliance period. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company intends to actively monitor the closing bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Requirement. However, there can be no assurance that the Company will regain compliance with the Minimum Bid Requirement during the 180 day compliance period, secure a second period of 180 days to regain compliance, or maintain compliance with the other Nasdaq listing requirements. If the Common Stock ceases to be listed for trading on The Nasdaq Capital Market, the Company would expect that the Common Stock would be traded on one of the three tiered marketplaces of the OTC Markets Group.공시 • Sep 13Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) entered into an agreement to acquire BlueSky Wellness Inc. for CAD 3.5 million.Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) entered into an agreement to acquire BlueSky Wellness Inc. for CAD 3.5 million on September 12, 2023. Under the terms of the agreement, BlueSky's shareholders will receive 3.5 million shares of Lucy Scientific's stock, as well as annual earn out payments based on a multiple of annual EBITDA in each of the next five years. Lucy expects to complete the acquisition within 90 days, and will work closely with the BlueSky team during the transition.공시 • Jul 14Lucy Scientific Discovery Inc. Announces Chief Executive Officer ChangesLucy Scientific Discovery Inc. announced the appointment of current Executive Chairman Richard Nanula as the new Chief Executive Officer, effective immediately. Nanula will retain his Chairman role while succeeding Chris McElvany as Chief Executive Officer, who will transition into a consulting role with the Company. Nanula brings to Lucy decades of senior leadership experience from several of the largest companies in the world having been a Senior Executive at The Walt Disney Company, Amgen, Colony Capital and Starwood Hotels and Resorts. Over the course of his career, Nanula had overseen more than $50 billion of M&A and financing transactions. The company’s founder and former CEO, Chris McElvany, will remain closely involved with the company as a consultant, leveraging his deep knowledge and industry expertise to support the transition.New Risk • Jul 07New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$3.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.1m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$18.8m market cap).공시 • Jun 07Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) made a proposal to acquire Pasithea Therapeutics Corp. (NasdaqCM:KTTA) for $22.2 million.Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) made a proposal to acquire Pasithea Therapeutics Corp. (NasdaqCM:KTTA) for $22.2 million on June 5, 2023. Under the terms of the offer, Lucy proposes to pay $0.60 in cash, and $0.25 cents in Lucy stock (NASDAQ: LSDI) for every share of Pasithea common stock. Given that Pasithea’s stock closed at $0.35 per share on June 1, 2023, the Proposal of $0.85 per share equates to 142% premium to Pasithea’s share price. In fact, the cash component alone represents a 71% premium. In the event that the proposal is not endorsed by Pasithea's Board of Directors, Lucy is prepared to present it directly to the Pasithea shareholders.공시 • May 23Lucy Scientific Discovery Inc.'S Functional Amanita Line Now Available for Purchase Through Retail ChannelsLucy Scientific Discovery Inc. announces Mindful, an innovative functional Amanita based product line is now available through multiple retail channels. Mindful by Lucy can be purchased on the company's online store, www.buytrippy.com, and through Hightimes.com. Mindful by Lucy is a carefully formulated functional product designed to enhance well-being and promote a mindful approach to life. Each capsule is crafted with precision, incorporating quality natural ingredients to deliver an exceptional experience. Lucy's online store, www.buytrippy.com, serves as a convenient platform for customers to explore and purchase the Mindful line. The user-friendly interface ensures a seamless shopping experience, allowing individuals to embark on their journey towards well-being with ease and confidence.Recent Insider Transactions Derivative • Feb 20President exercised options to buy US$1.1m worth of stock.On the 13th of February, Christopher McElvany exercised options to buy 366k shares at a strike price of around US$2.40, costing a total of US$879k. This transaction amounted to 33% of their direct individual holding at the time of the trade. Since September 2022, Christopher has owned 1.32m shares directly. This was the only transaction from an insider over the last 12 months.Board Change • Feb 10High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Livio Susin is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Feb 10Lucy Scientific Discovery Inc. has completed an IPO in the amount of $7.5 million.Lucy Scientific Discovery Inc. has completed an IPO in the amount of $7.5 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 1,875,000 Price\Range: $4지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 LSDI.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: LSDI.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Lucy Scientific Discovery 배당 수익률 vs 시장LSDI.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (LSDI.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Pharmaceuticals)2.1%분석가 예측 (LSDI.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 LSDI.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 LSDI.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 LSDI.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: LSDI.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 13:50종가2026/05/18 00:00수익2023/12/31연간 수익2023/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Lucy Scientific Discovery Inc.는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Casey RyanWestPark Capital, Inc.Karen SterlingWestPark Capital, Inc.
공시 • Sep 06The Nasdaq Stock Market to Delist Common Stock of Lucy Scientific DiscoveryThe Nasdaq Stock Market announced that it will delist the common stock of Lucy Scientific Discovery Inc. The company’s Securities were suspended on July 1, 2024, and have not traded on Nasdaq since that time.
공시 • Jul 02Nasdaq Determines to Delist the Lucy Scientific Discovery's Common SharesAs previously disclosed, on May 7, 2024, Lucy Scientific Discovery Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating that based on the review of the Nasdaq staff, the Company’s lack of compliance with the requirement that a listed company’s stockholders’ equity be at least $2.5 million pursuant to Nasdaq Listing Rule 5550(b), would have lead to the suspension of the trading of the Company’s common shares at the opening of business on May 16, 2024. The Company needed to appeal the delisting determination by May 14th and request a hearing before an independent Nasdaq Hearings Panel to avoid this trading suspension. The Company timely submitted its appeal, which stayed the delisting of the Company’s securities on Nasdaq until the hearing was held on June 25, 2024. Furthermore, as previously disclosed, on May 21, 2024, the Company received a letter from the Staff stating that, per Nasdaq Listing Rule 5250(c)(1), the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024, which served as an additional basis for delisting the Company’s securities from Nasdaq. On June 25, 2024, the Company participated in a hearing before the Panel regarding its plan to regain compliance with the Minimum Stockholders’ Equity Requirement and the Filings Rule. On June 27, 2024, the Company received notice from Nasdaq that the Panel has determined to delist the Company’s common shares. Suspension of trading in the Company’s common shares will be effective at the open of trading on July 1, 2024. Following the delisting of its common shares from the Nasdaq Capital Market, the Company will continue to be a reporting company under the Securities Exchange Act of 1934. The Company expects its common shares will commence trading on the OTC Markets Group platform at the open of trading on July 1, 2024 under the symbol “LSDI.” The Company has a period of 15 days from the date of the notice letter to submit a written request for a review of the Panel’s delisting determination by the Nasdaq Listing and Hearing Review Council.
공시 • May 29Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)Lucy Scientific Discovery Inc. announced that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule"). On May 21, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") that, per Nasdaq Listing Rule 5250(c)(1) (the "Filings Rule"), the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024, which serves as an additional basis for delisting the Company's securities from Nasdaq. The Company intends to request the continued listing of its common shares on Nasdaq pending its compliance with the Stockholders' Equity Rule and the Filings Rule. However, there can be no assurance that the Panel will grant the Company's request or that the Company will ultimately regain compliance with all applicable requirements for continued listing on Nasdaq.
공시 • May 17Lucy Scientific Discovery Inc. announced delayed 10-Q filingOn 05/15/2024, Lucy Scientific Discovery Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 12Brian Zasitko, Chief Financial Officer of Lucy Scientific Discovery Inc., Resigns, Effective May 17, 2024On May 3, 2024, Brian Zasitko, Chief Financial Officer of Lucy Scientific Discovery Inc., resigned, effective May 17, 2024.
공시 • May 11+ 1 more updateLucy Scientific Discovery Inc. Announces Resignation of Livio Susin, Member of the Board of DirectorsOn April 25, 2024, Livio Susin, a member of the Board of Directors of Lucy Scientific Discovery Inc., resigned, effective immediately. Mr. Susin did not resign as a result of any disagreement with the Company, known to an executive officer of the Company, on any matter relating to the Company's operations, policies or practices.
공시 • Feb 17Lucy Scientific Discovery Inc. Announces 1-For-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementLucy Scientific Discovery Inc. announced that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The reverse share split will become effective on February 26, 2024 (the “Effective Date”), and the shares are expected to begin trading on the split-adjusted basis on the Nasdaq Stock Exchange (“Nasdaq”) under the Company's existing trading symbol “LSDI” at the market open on February 26, 2024. In conjunction with the reverse split, the new CUSIP number will be 54960E203. On the Effective Date, every 10 issued and outstanding shares of the Company’s Common Stock will be converted automatically into one share of the Company’s Common Stock without any change in the par value per share.
New Risk • Feb 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$6.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$6.3m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 27% per year over the past 5 years. Revenue is less than US$1m (US$17k revenue). Market cap is less than US$10m (US$4.33m market cap). Minor Risk Shareholders have been diluted in the past year (8.4% increase in shares outstanding).
Board Change • Dec 28High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Livio Susin is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Sep 28Lucy Scientific Discovery Receives Non-Compliance Notice From NasdaqOn September 21, 2023, Lucy Scientific Discovery Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, no par value per share (the “Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no immediate effect on the continued listing status of the Common Stock on The Nasdaq Capital Market, and, therefore, the Company's listing remains fully effective. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company is provided a compliance period of 180 calendar days from the date of the Notice, or until March 19, 2024, to regain compliance with the Minimum Bid Requirement. To regain compliance, the closing bid price of the Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to March 19, 2024. If the Company is not in compliance with the Minimum Bid Requirement by March 19, 2024, the Company may be afforded a second 180 calendar day compliance period. To qualify for this additional compliance period, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price requirement. The Company will continue to monitor the closing bid price of its Common Stock and seek to regain compliance with all applicable Nasdaq requirements within the allotted compliance period. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company intends to actively monitor the closing bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Requirement. However, there can be no assurance that the Company will regain compliance with the Minimum Bid Requirement during the 180 day compliance period, secure a second period of 180 days to regain compliance, or maintain compliance with the other Nasdaq listing requirements. If the Common Stock ceases to be listed for trading on The Nasdaq Capital Market, the Company would expect that the Common Stock would be traded on one of the three tiered marketplaces of the OTC Markets Group.
공시 • Sep 13Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) entered into an agreement to acquire BlueSky Wellness Inc. for CAD 3.5 million.Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) entered into an agreement to acquire BlueSky Wellness Inc. for CAD 3.5 million on September 12, 2023. Under the terms of the agreement, BlueSky's shareholders will receive 3.5 million shares of Lucy Scientific's stock, as well as annual earn out payments based on a multiple of annual EBITDA in each of the next five years. Lucy expects to complete the acquisition within 90 days, and will work closely with the BlueSky team during the transition.
공시 • Jul 14Lucy Scientific Discovery Inc. Announces Chief Executive Officer ChangesLucy Scientific Discovery Inc. announced the appointment of current Executive Chairman Richard Nanula as the new Chief Executive Officer, effective immediately. Nanula will retain his Chairman role while succeeding Chris McElvany as Chief Executive Officer, who will transition into a consulting role with the Company. Nanula brings to Lucy decades of senior leadership experience from several of the largest companies in the world having been a Senior Executive at The Walt Disney Company, Amgen, Colony Capital and Starwood Hotels and Resorts. Over the course of his career, Nanula had overseen more than $50 billion of M&A and financing transactions. The company’s founder and former CEO, Chris McElvany, will remain closely involved with the company as a consultant, leveraging his deep knowledge and industry expertise to support the transition.
New Risk • Jul 07New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$3.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.1m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$18.8m market cap).
공시 • Jun 07Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) made a proposal to acquire Pasithea Therapeutics Corp. (NasdaqCM:KTTA) for $22.2 million.Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) made a proposal to acquire Pasithea Therapeutics Corp. (NasdaqCM:KTTA) for $22.2 million on June 5, 2023. Under the terms of the offer, Lucy proposes to pay $0.60 in cash, and $0.25 cents in Lucy stock (NASDAQ: LSDI) for every share of Pasithea common stock. Given that Pasithea’s stock closed at $0.35 per share on June 1, 2023, the Proposal of $0.85 per share equates to 142% premium to Pasithea’s share price. In fact, the cash component alone represents a 71% premium. In the event that the proposal is not endorsed by Pasithea's Board of Directors, Lucy is prepared to present it directly to the Pasithea shareholders.
공시 • May 23Lucy Scientific Discovery Inc.'S Functional Amanita Line Now Available for Purchase Through Retail ChannelsLucy Scientific Discovery Inc. announces Mindful, an innovative functional Amanita based product line is now available through multiple retail channels. Mindful by Lucy can be purchased on the company's online store, www.buytrippy.com, and through Hightimes.com. Mindful by Lucy is a carefully formulated functional product designed to enhance well-being and promote a mindful approach to life. Each capsule is crafted with precision, incorporating quality natural ingredients to deliver an exceptional experience. Lucy's online store, www.buytrippy.com, serves as a convenient platform for customers to explore and purchase the Mindful line. The user-friendly interface ensures a seamless shopping experience, allowing individuals to embark on their journey towards well-being with ease and confidence.
Recent Insider Transactions Derivative • Feb 20President exercised options to buy US$1.1m worth of stock.On the 13th of February, Christopher McElvany exercised options to buy 366k shares at a strike price of around US$2.40, costing a total of US$879k. This transaction amounted to 33% of their direct individual holding at the time of the trade. Since September 2022, Christopher has owned 1.32m shares directly. This was the only transaction from an insider over the last 12 months.
Board Change • Feb 10High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Livio Susin is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Feb 10Lucy Scientific Discovery Inc. has completed an IPO in the amount of $7.5 million.Lucy Scientific Discovery Inc. has completed an IPO in the amount of $7.5 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 1,875,000 Price\Range: $4